Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Malfroy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Transfusion Medicine (Oxford, England)|August 3, 2004
Using patient-identifiable data for epidemiological researchM Malfroy, C A Llewelyn, T Johnson, et al.
Transfusion Medicine (Oxford, England)|April 28, 2009
The EASTR study: a new approach to determine the reasons for transfusion in epidemiological studiesC A Llewelyn, A W Wells, M Amin, et al.
Transfusion Medicine (Oxford, England)|September 9, 2009
The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood ServiceA W Wells, C A Llewelyn, A Casbard, et al.
Oncogenesis|July 26, 2016
TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16(INK4a) protein expressionP Parroche, G Roblot, F Le Calvez-Kelm, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Transfusion Medicine (Oxford, England)|August 3, 2004
Using patient-identifiable data for epidemiological researchM Malfroy, C A Llewelyn, T Johnson, et al.
Transfusion Medicine (Oxford, England)|April 28, 2009
The EASTR study: a new approach to determine the reasons for transfusion in epidemiological studiesC A Llewelyn, A W Wells, M Amin, et al.
Transfusion Medicine (Oxford, England)|September 9, 2009
The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood ServiceA W Wells, C A Llewelyn, A Casbard, et al.
Oncogenesis|July 26, 2016
TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16(INK4a) protein expressionP Parroche, G Roblot, F Le Calvez-Kelm, et al.
Pageof 1